CIK 0001512762 · Accelerated filer<br>Smaller reporting company
Coherus Oncology, Inc.
Sign in to watch- Ticker
- CHRS
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 273615821
- Phone
- (650) 649-3530
- Business address
- C/O DENNIS M. LANFEAR, 333 TWIN DOLPHIN DR, SUITE 600, REDWOOD CITY, CA, 94065
- Former names
- Coherus BioSciences, Inc., BioGenerics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-06-03 | Newcomer Lee Nisley Director | Grant or award · Stock Option (Right to Buy) | +112,000 | 112,000 | ||
| 2024-06-03 | TZOUMAKAS KIMBERLY JO Director | Grant or award · Stock Option (Right to Buy) | +112,000 | 112,000 | ||
| 2024-06-03 | O'Donnell-Tormey Jill Director | Grant or award · Stock Option (Right to Buy) | +112,000 | 112,000 | ||
| 2024-02-20 | Erbez Georgia Director | Grant or award · Stock Option (Right to Buy) | +54,000 | 54,000 | ||
| 2024-02-09 | Wahlstrom Mats Director | Gift | −99,988 | 0 | ||
| 2024-02-09 | Wahlstrom Mats Director | Gift | +99,988 | 99,988 | ||
| 2024-02-01 | Wahlstrom Mats Director | Option exercise | +14,997 | $1.67 | $25K | 54,997 |
| 2024-02-01 | Wahlstrom Mats Director | Option exercise | +44,991 | $1.67 | $75K | 99,988 |
| 2024-02-01 | Wahlstrom Mats Director | Option exercise · Stock Option (Right to Buy) | −14,997 | 0 | ||
| 2024-02-01 | Wahlstrom Mats Director | Option exercise · Stock Option (Right to Buy) | −44,991 | 0 | ||
| 2024-01-20 | Lanfear Dennis M President & CEO | Shares withheld for taxes | −11,218 | $2.44 | $27K | 708,694 |
| 2024-01-20 | Reider Paul Chief Commercial Officer | Shares withheld for taxes | −4,854 | $2.44 | $12K | 81,277 |
| 2024-01-20 | McMichael Bryan J See Remarks | Shares withheld for taxes | −1,707 | $2.44 | $4K | 22,972 |
| 2024-01-07 | McMichael Bryan J See Remarks | Shares withheld for taxes | −1,707 | $2.87 | $5K | 24,679 |
| 2024-01-05 | Lanfear Dennis M President & CEO | Grant or award · Stock Option (Right to Buy) | +575,000 | 575,000 | ||
| 2024-01-04 | Lanfear Dennis M President & CEO | Shares withheld for taxes | −11,781 | $2.92 | $34K | 719,912 |
| 2024-01-04 | Reider Paul Chief Commercial Officer | Shares withheld for taxes | −2,275 | $2.92 | $7K | 86,131 |
| 2024-01-02 | McMichael Bryan J See Remarks | Grant or award · Stock Option (Right to Buy) | +125,000 | 125,000 | ||
| 2024-01-02 | Reider Paul Chief Commercial Officer | Grant or award · Stock Option (Right to Buy) | +160,000 | 160,000 | ||
| 2023-12-31 | Stilwell McDavid Chief Financial Officer | Shares withheld for taxes | −18,440 | $3.33 | $61K | 75,305 |
Page 5 of 39 · 768 trades